Royal Philips unveiled Lumify, its first app-based ultrasound solution, offering high-quality imaging on a compatible smart device through a subscription model.

The setup involves the 510(k) cleared Lumify ultrasound transducer, which will be available in the U.S. later this year, and a “regular” tablet physicians may already have in their office. Also as part of the package, users get access to an online portal where they can manage their device and access Philips’ support, training and IT services.

“Ultrasound’s versatility, portability and safety enabled it to become one of the most widely used first-line diagnostic tools,” said Vitor Rocha, CEO of Ultrasound for Philips. “With the advent of App-Based Ultrasound, we strive to bring the value and benefits of ultrasound to more places across the health continuum.”

The setup involves the 510(k) cleared Lumify ultrasound transducer and a “regular” tablet physicians may already have in their office.Lumify is designed to seamlessly integrate with patient profiles and a health system’s equipment using cloud-enabled technology. Additionally, data will be accessible on the Philips HealthSuite Digital Platform, an open and secure, cloud-based IT infrastructure, allowing users and health systems access to powerful data and analytics to help improve patient care.

Central to App-Based Ultrasound’s development and continued evolution is Philips’ Ultrasound Consortium launched last year to drive the creation of valuable applications. Consisting of experts from across the health continuum, the Consortium will explore ways to extend the reach of ultrasound applications into the hands of more healthcare providers as they guide patients from diagnosis to treatment and recovery. Working together and in parallel with customer insights, the Consortium will inform the next generation of App-Based Ultrasound.